The IPO Buzz: Chips, SPACs and Saudi Aramco

Chips and SPACs are in the spotlight on this week’s IPO Calendar. And there’s big news about an IPO that the American public can’t buy – the long-awaited Saudi Aramco deal. (More on that gigantic IPO in a minute.) Bankers plan to price eight IPOs this week and raise about $684 million. Two chip companies […]

November 17, 2019 Read More

The IPO Buzz: A Better-Than-Usual November

Two IPOs slipped on to the IPO Calendar late Thursday afternoon for pricing during the week of Nov. 18. That gave Wall Street some IPO action for the third week of November, when previously there was none. This isn’t to say that things have turned quiet. November 2019 is off to a better-than-usual start.(There’s just […]

November 11, 2019 Read More

The IPO Buzz: November Opens with a $2.4 Billion Week

The first week of November features a $2.4 billion IPO Calendar, with one deal – GFL Environmental – accounting for most of that volume. GFL, the Canadian trash and recycling giant, aims to raise $1.9 billion. It’s among 10 IPOs on tap this week. Health care is the dominant sector this week. Five of the […]

November 3, 2019 Read More

The IPO Buzz: An IPO Trio for Halloween Week

Just three IPOs are on the calendar this week, when Halloween falls on Thursday.  That’s a wrap as well for October.  A cannabis SPAC, a biotech and an online platform for Chinese real estate agents are in this week’s IPO mix. Bankers expect these three deals to raise $283 million, based on the midpoint of […]

October 27, 2019 Read More

The IPO Buzz: Eight IPOs in an $830.5 Million Week

A fertility benefits management company is among eight deals on this week’s IPO Calendar. Bankers expect to raise $830.5 million. Progyny (PGNY proposed) manages fertility benefits for some of the country’s most prominent employers, its prospectus says. Some would say that Progyny’s IPO is a sign of the times. More employers are offering insurance coverage […]

October 20, 2019 Read More

The IPO Buzz: Recommended Reading

You probably wouldn’t buy a car or make any other major purchase without doing some homework. The same rule applies to buying stock in an IPO. Reading the prospectus isn’t just fundamental. It could prevent heartburn or a hole in your bank account. Just three deals are on tap this week, and only two are […]

October 13, 2019 Read More

The IPO Buzz: Two Biotechs and a Bank

Two biotechs and a Midwestern bank make up this week’s IPO Calendar. That’s it. Bankers expect to raise $550.22 million from these three deals. This lineup extends the trend last week when five biotechs plus a Southern bank were set to go public. Two of those five biotech deals got pulled last week “due to […]

October 6, 2019 Read More

The IPO Buzz: October’s Biotech Brigade

It seems every time the IPO Calendar starts to run dry, you can count on bankers filling up the pages with healthcare deals. This week is a classic example. Six IPOs are on tap for the first week of October – and five are in the healthcare sector, either biotech or biopharma companies. (We’ll have […]

September 29, 2019 Read More

The IPO Buzz: A $1.8 Billion Week

This week’s IPO Calendar lists $1.8 billion in IPOs. By recent standards, that’s a lot of volume. But this week is an unusual one. It breaks down into just three names: Peloton Interactive (PTON proposed) plans to raise $1.1 billion. Endeavor Group Holdings (EDR proposed) expects to raise $600 million and Oportun Financial (OPRT proposed) […]

September 23, 2019 Read More

The IPO Buzz: Datadog & Ping Lead the Pack

Datadog and Ping Identity are the two most highly anticipated deals among the six IPOs scheduled to make their debuts this week. Collectively, IPO bankers expect to raise an estimated $1.73 billion from this six-pack of deals. At this pace, this is a worthwhile IPO Calendar. On an annualized basis, this IPO traffic would amount […]

September 15, 2019 Read More
Page 64 of 132« First...102030...6263646566...708090...Last »